AstraZeneca PLC
Connections
Quotes
The NCATS team was crucial in bringing together our group at Yale, together with AstraZeneca, to test the efficacy of this drug in Alzheimer's disease. Now, we're beginning a trial, together with AstraZeneca, in order to find out whether this drug can slow down the loss of memory and preserve memory function in the millions of Americans suffering with this disease.
The NCATS team was crucial in bringing together our group at Yale, together with AstraZeneca, to test the efficacy of this drug in Alzheimer's disease. Now, we're beginning a trial, together with AstraZeneca, in order to find out whether this drug can slow down the loss of memory and preserve memory function in the millions of Americans suffering with this disease.
AstraZeneca’s investment is excellent news for the UK life sciences industry. It strengthens our global competitiveness and supports our aim of making the UK the best place in the world for the discovery and commercialisation of medical innovations. These are key themes of the Government's life sciences strategy.More quotes »
Newsday's coverage
-
AstraZeneca in $560 m deal for respiratory firm
-- British drugmaker AstraZeneca PLC says it is to acquire Pearl Therapeutics Inc., a Redwood-City, California-based company involved in therapies for asthma and chronic obstructive pulmonary disease for at least $560 million.The deal -- which could involve Read more »
Around the web
-
AstraZeneca and NGM Collaborate - Analyst Blog
cancer) and BIND Therapeutics (for development and commercialization cancer nanomedicine) are efforts in that direction. AstraZeneca entered into a number acquisition deals including Pearl Therapeutics, Omthera Pharmaceuticals, Inc. (OMTH - Snapshot Report) 6/18/13 from Zacks Investment Research Read more »
-
AstraZeneca turnaround plan may take four years, warns drugs chief
Cookies are small data files which are sent to your browser (Internet Explorer, Firefox, Chrome etc) from a website you visit. They are stored on your electronic device. This is a type of cookie which is collected by Adobe Flash media player (it is also ca 6/18/13 from The Scotsman Read more »
-
AstraZeneca homes in on new HQ and research site in Cambridge
new CEO has zeroed in on a site for its new headquarters and R&D center in the U.K. Over the next three years the pharma company ($AZN) plans to build a $500 million complex on an 11-acre site at the Cambridge BioMedical Campus. The new campus will house its 6/18/13 from FiercePharma Read more »
-
AstraZeneca’s chief executive on the fight against cancer and the firm’s new Cambridge HQ
science, the best possible people, and the best possible collaboration, because the world of science is a big ocean, but AstraZeneca is very small in this big ocean, and collaboration is crucial. “Cambridge is an outstanding location with the best scientists 6/18/13 from Cambridge Evening News Read more »
-
AstraZeneca turnaround is three-four year journey, says CEO
Executive Officer (CEO) of AstraZeneca, Pascal Soriot, poses for a photograph in this undated picture provided by AstraZeneca in London on March 12, 2013. LONDON (Reuters) - Turning around drugmaker AstraZeneca will be a long haul, with a strategy of revamping 6/18/13 from Reuters Read more »
